Assessing thyroid cancer risk using polygenic risk scores.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: 2020-03-04

DOI: 10.1073/pnas.1919976117

Affiliations: 24

Authors: 21

Go to article
Institutions Share
deCODE Genetics, Inc., Iceland 0.19
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA) 0.12
Landspitali - The National University Hospital of Iceland, Iceland 0.11
OSU Division of Endocrinology, Diabetes and Metabolism, United States of America (USA) 0.10
Radboud Institute for Health Sciences (RIHS), RU, Netherlands 0.07
OSU Department Cancer Biology and Genetics, United States of America (USA) 0.05
Department of Head and Neck Surgery, MD Anderson Cancer Center, United States of America (USA) 0.05
Department of Epidemiology, MD Anderson Cancer Center, United States of America (USA) 0.05
UCHealth Diane O’Connor Thompson Breast Center, United States of America (USA) 0.05
Radboud Institute for Molecular Life Sciences (RIMLS), RU, Netherlands 0.05
Faculty of Medicine, University of Iceland, Iceland 0.04
UMC Division of Heart and Lungs, Netherlands 0.03
Department of Internal Medicine, RU, Netherlands 0.02
OSU Department of Internal Medicine, United States of America (USA) 0.02
Icelandic Cancer Registry (ICR), Iceland 0.02
Durrer Center for Cardiovascular Research (Durrer Center), Netherlands 0.01
UCL Institute of Cardiovascular Science (ICS), United Kingdom (UK) 0.01
UCL Institute of Health Informatics, United Kingdom (UK) 0.01
Farr Institute of Health Informatics Research, United Kingdom (UK) 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER